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Background
The variant surface antigen PfEMP1 (Plasmodium falci-
parum erythrocyte membrane protein 1) encoded by the
polymorphic multi-copy var gene family plays an impor-
tant role in parasite biology and the host-parasite interac-
tions. Sequestration and antigenic variation is an essential
component in the survival and pathogenesis of Plasmo-
dium falciparum and contributes to chronic infection .
The DBLa domain of PfEMP1 is a potential target for
immuno-epidemiological studies and has been visualized
as a vaccine candidate against severe malaria. Extensive
var gene diversity (DBLa domain of PfEMP1) is an impor-
tant aspect of pathogenesis in parasite lines. Specific host
receptors like heparin, heparan sulphate, blood group A
and complement receptor 1 have been reported to bind
DBLa domain. Although heparin has been experimentally
shown to disrupt the parasite-host interaction and effec-
tively disrupt rosetting, the binding sites for the DBLa
domain and mechanism behind heparin-mediated rosette
inhibition have not been elucidated.
Materials and methods
3D structures and epitopes of DBLa domain in 3D7 and
in two parasite isolates have been predicted and com-
pared. Docking studies on DBLa domains with human
GAG receptors (heparin and heparan sulphate) to predict
the strength of association between the protein–ligand
interactions were performed.
Results
The DBLa domain structures showed extensive diversity
and polymorphism in their binding sites. The linear as
well as conformational epitope prediction analysis pre-
dicted several B cell epitopes at variable positions in dif-
ferent DBLa domain variants [1]. The docking results
indicate that heparin binds more effectively with high
affinity as compared to heparan sulphate with some
common interacting residues [2]. These common resi-
dues can play an important role in rosetting and will aid
in the designing of inhibitors specific to the interactions
between DBLa and heparin or heparan sulphate would
be important in malaria treatment.
Conclusions
Thus such an analysis may lead to the development of
novel interference strategies to block red blood cell
invasion and provide protection against malaria and pro-
vide an insight into the complexities of host parasite
interactions.
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